ARCHIVES

Coulter And Venture Capital Firm Form Company To Develop B1 Antibody For NHL

This article is from The Cancer Letter archive.

Vol. 21 No. 17 | April 28, 1995

Download PDF Visit The Full Archive

Related Articles

NCAB Working Group To Hold Open And Closed Sessions

January 20, 1995

In Brief: Robert Miller To Head International Affairs Office’ Pitot: No Basis for 20% Estimate

December 1, 1978

More Debate Due On Organ Site Program; First Round Reviewed By DRG “Slaughtered”

January 28, 1983

FDA News: Zydelig approved in three B-cell blood cancers

August 1, 2014

5-Day Strut-based Brachytherapy Produced Low Recurrence Rates

May 25, 2012

In Brief: Sabin Leaves Frederick For So. Carolina; Georgia Worried Over Missing Out On Comprehensive Center

October 11, 1974